ChemExpress Secures Rare Flawless Score in First U.S. Health Regulator Audit

Ma’anshan, Monday, 2 November 2026.
ChemExpress achieved a rare, observation-free clearance during its initial U.S. FDA audit at its Ma’anshan plant, validating the facility’s manufacturing standards for American pharmaceutical supply chains.